Avacta Group (AVCT) News Today GBX 47 -1.00 (-2.08%) As of 01/31/2025 12:30 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancerJanuary 17, 2025 | msn.comAvacta Group (LON:AVCT) Stock Price Passes Below Two Hundred Day Moving Average - Here's WhyAvacta Group (LON:AVCT) Share Price Passes Below 200-Day Moving Average - Here's What HappenedJanuary 15, 2025 | marketbeat.comAvacta Group (LON:AVCT) Shares Pass Below 200 Day Moving Average - What's Next?Avacta Group (LON:AVCT) Stock Price Crosses Below 200 Day Moving Average - Should You Sell?January 14, 2025 | marketbeat.comAvacta Group (LON:AVCT) Trading Up 13.2% - Time to Buy?Avacta Group (LON:AVCT) Trading 13.2% Higher - Should You Buy?January 6, 2025 | marketbeat.comAvacta Group (LON:AVCT) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?Avacta Group (LON:AVCT) Stock Price Crosses Below Two Hundred Day Moving Average - Here's WhyDecember 28, 2024 | marketbeat.comAvacta Group (LON:AVCT) Stock Price Passes Below 200 Day Moving Average - What's Next?Avacta Group (LON:AVCT) Stock Passes Below Two Hundred Day Moving Average - Time to Sell?December 20, 2024 | marketbeat.comAvacta Group Opens Phase 1b Trial for Targeted Cancer TherapyDecember 12, 2024 | markets.businessinsider.comAvacta Group (LON:AVCT) Stock Price Up 11.2% - What's Next?Avacta Group (LON:AVCT) Trading Up 11.2% - Should You Buy?November 21, 2024 | marketbeat.comInvestors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five yearsNovember 13, 2024 | finance.yahoo.comAvacta Group (LON:AVCT) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedAvacta Group (LON:AVCT) Stock Price Crosses Below 200 Day Moving Average - Here's What HappenedNovember 5, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Crosses Above 200 Day Moving Average - What's Next?Avacta Group (LON:AVCT) Stock Price Passes Above 200-Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Passes Above 200-Day Moving Average - Time to Sell?Avacta Group (LON:AVCT) Stock Price Passes Above 200 Day Moving Average - What's Next?October 18, 2024 | marketbeat.comAvacta Group (LON:AVCT) Stock Price Up 7.2% - What's Next?Avacta Group (LON:AVCT) Shares Up 7.2% - What's Next?October 10, 2024 | marketbeat.comAvacta Group Share Chat (AVCT)October 3, 2024 | lse.co.ukAvacta Group First Half 2024 Earnings: UK£0.038 loss per share (vs UK£0.043 loss in 1H 2023)October 3, 2024 | uk.finance.yahoo.comAvacta Group (LON:AVCT) Stock Price Up 8.4%Avacta Group (LON:AVCT) Stock Price Up 8.4%October 3, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Crosses Above Two Hundred Day Moving Average of $56.59Avacta Group (LON:AVCT) Share Price Passes Above 200 Day Moving Average of $56.59September 25, 2024 | marketbeat.comAvacta Group (LON:AVCT) Shares Pass Above 200-Day Moving Average of $56.62Avacta Group (LON:AVCT) Shares Pass Above Two Hundred Day Moving Average of $56.62September 11, 2024 | marketbeat.comAvacta Group Plc (LON:AVCT) Insider Tony Peter Gardiner Sells 500,000 SharesSeptember 4, 2024 | insidertrades.comAvacta Group (LON:AVCT) Stock Price Crosses Above Two Hundred Day Moving Average of $58.99Avacta Group (LON:AVCT) Shares Cross Above 200 Day Moving Average of $58.99August 24, 2024 | marketbeat.comAvacta Group Plc (AVCTF)July 27, 2024 | uk.finance.yahoo.comAvacta Group Plc reports FY resultsMay 1, 2024 | msn.comAvacta Group (LON:AVCT) investors are sitting on a loss of 82% if they invested three years agoMay 1, 2024 | finance.yahoo.comUpdated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024March 6, 2024 | finance.yahoo.comAvacta Group: Appointment of Chief Business OfficerDecember 19, 2023 | finanznachrichten.deAppointment of Chief Business OfficerDecember 19, 2023 | finance.yahoo.comALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study DataDecember 13, 2023 | finance.yahoo.comAnixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardOctober 23, 2023 | finance.yahoo.comIf I’d invested £1,000 in Avacta shares 5 years ago, here’s how much I’d have nowSeptember 11, 2023 | msn.comAvacta Group Share ChatAugust 11, 2023 | lse.co.ukAvacta Completes Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | marketwatch.comAvacta Group plc: Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | finanznachrichten.deAvacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | finance.yahoo.comAvacta Group Says No Fundraising Imminent; Shares RiseJune 19, 2023 | marketwatch.comAVCT.L - Avacta Group PlcJune 6, 2023 | uk.finance.yahoo.comFirst Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical StudyApril 27, 2023 | finance.yahoo.comAvacta Group plc: Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation StudyApril 5, 2023 | finanznachrichten.deAvacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics DivisionMarch 28, 2023 | finance.yahoo.comIs the Avacta share price dip a buying opportunity?March 16, 2023 | msn.comBlock Listing Application to AIMJanuary 17, 2023 | lse.co.ukAvacta Group Plc (LON:AVCT) is favoured by institutional owners who hold 58% of the companyOctober 21, 2022 | finance.yahoo.comAvacta Group Plc (AVCT.L)October 1, 2022 | uk.finance.yahoo.comAvacta's AVA6000 Gets FDA Orphan Drug Designation To Treat Soft Tissue Sarcoma; Stock UpSeptember 5, 2022 | nasdaq.comLG Chem Renews License Triggering Payment to AvactaJune 30, 2022 | finance.yahoo.comAffyXell Expands its Strategic Partnership With...May 16, 2022 | benzinga.comAvacta full-year results push shares higherApril 6, 2022 | proactiveinvestors.comIs Avacta Group (LON:AVCT) In A Good Position To Invest In Growth?March 19, 2022 | finance.yahoo.comWhat’s next for the Avacta share price?March 17, 2022 | uk.finance.yahoo.comThe Avacta share price: buy or avoid like the plague?March 1, 2022 | uk.news.yahoo.comAvacta Group selects second pre|CISION drug candidate for developmentJanuary 18, 2022 | msn.com Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address AVCT Media Mentions By Week AVCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVCT News Sentiment▼0.000.69▲Average Medical News Sentiment AVCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVCT Articles This Week▼00▲AVCT Articles Average Week Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Biomedica News PureTech Health News Faron Pharmaceuticals Oy News Bioventix News 4basebio News hVIVO News Futura Medical News Scancell News Redx Pharma News e-therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AVCT) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
